Shorter radiation for breast cancer shows promise in small trial
NCT ID NCT04913532
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a shorter course of radiation therapy for people with early-stage breast cancer after lumpectomy. The goal was to see if this approach causes fewer skin side effects. 35 participants received the treatment, and researchers measured how many developed moderate to severe skin reactions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hypofractionated radiation with simultaneous integrated boost
- What this could lead to
- If successful, this could offer a shorter, more convenient radiation course for early breast cancer with fewer skin side effects.
- What could go wrong
- This is a small, single-group trial with only 35 participants, so results may not apply to everyone. It only looked at short-term side effects, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADJUVANT RADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Shijitan Hospital
Beijing, 100038, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?